文献速递中医内科中药与中成药合理使用

整合虚拟筛选与体外验证识别中药复方中多靶点抗AD化学成分

Identification of Multi-Target Anti-AD Chemical Constituents From Traditional Chinese Medicine Formulae by Integrating Virtual Screening and In Vitro Validation.
PubMed 文献 · Front Pharmacol · 2021-07-16

本研究构建抗AD中药复方化合物数据库,通过虚拟筛选平台预测多靶点成分,筛选出226个具有3个及以上潜在AD相关靶点的化学成分,从中选择16个进行多种细胞模型验证。实验结果表明,包括Nonivamide、Bavachromene和3,4-二甲氧基肉桂酸在内的12个化合物能保护模型细胞免受AD相关损伤,具有潜在抗AD活性;分子对接研究了Nonivamide与预测靶点的结合模式。研究为中药中抗AD多靶点化合物的发现提供了理论与实验基础。

要点

  • 从抗AD中药复方中虚拟筛选出226个具有≥3个潜在AD相关靶点的化学成分。
  • 12个化合物在KCl、Aβ、OA、SNP、H2O2诱导的SH-SY5Y及LPS诱导的BV2细胞模型中显示抗AD活性。
  • Nonivamide等化合物通过多靶点机制发挥潜在抗AD作用,分子对接揭示了其结合模式。

核心结论

  • 从抗AD中药复方中发现了12个潜在的多靶点抗AD化合物,为深入研究奠定了基础。

研究设计与样本

  • 研究构建了抗AD中药复方来源的化合物数据库,并利用本实验室建立的抗AD多靶点药物预测平台进行虚拟筛选。

主要发现

  • 虚拟筛选收集到226个具有3个或以上潜在AD相关靶点的化学成分。
  • 从226个成分中选出16个预测通过多种机制抗AD的化合物进行生物验证。
  • 实验结果显示,包括Nonivamide、Bavachromene和3,4-二甲氧基肉桂酸在内的12个化合物能保护模型细胞免受AD相关损伤,具有潜在抗AD活性。
  • 分子对接研究揭示了Nonivamide与其预测靶点的可能结合模式。

关键数值与推荐

  • 虚拟筛选标准为化学成分具有3个或以上潜在AD相关靶点。

临床怎么用

  • 本研究发现的12个多靶点抗AD化合物可为中药新药研发提供候选分子,但尚未进入临床研究。

局限性

  • 研究仅进行了体外细胞模型验证和分子对接预测,缺乏体内实验和临床数据支持。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Alzheimer's disease (AD) is a neurodegenerative disease that seriously threatens the health of the elderly. At present, no drugs have been proven to cure or delay the progression of the disease. Due to the multifactorial aetiology of this disease, the multi-target-directed ligand (MTDL) approach provides an innovative and promising idea in search for new drugs against AD. In order to find potential multi-target anti-AD drugs from traditional Chinese medicine (TCM) formulae, a compound database derived from anti-AD Chinese herbal formulae was constructed and predicted by the anti-AD multi-target drug prediction platform established in our laboratory. By analyzing the results of virtual screening, 226 chemical constituents with 3 or more potential AD-related targets were collected, from which 16 compounds that were predicted to combat AD through various mechanisms were chosen for biological validation. Several cell models were established to validate the anti-AD effects of these compounds, including KCl, Aβ, okadaic acid (OA), SNP and H2O2 induced SH-SY5Y cell model and LPS induced BV2 microglia model. The experimental results showed that 12 compounds including Nonivamide, Bavachromene and 3,4-Dimethoxycinnamic acid could protect model cells from AD-related damages and showed potential anti-AD activity. Furthermore, the potential targets of Nonivamide were investigated by molecular docking study and analysis with CDOCKER revealed the possible binding mode of Nonivamide with its predicted targets. In summary, 12 potential multi-target anti-AD compounds have been found from anti-AD TCM formulae by comprehensive application of computational prediction, molecular docking method and biological validation, which laid a theoretical and experimental foundation for in-depth study, also providing important information and new research ideas for the discovery of anti-AD compounds from traditional Chinese medicine.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Zhang B, Zhao J, Wang Z, et al. Identification of Multi-Target Anti-AD Chemical Constituents From Traditional Chinese Medicine Formulae by Integrating Virtual Screening and In Vitro Validation. Front Pharmacol. 2021. PMID: 34335272. doi:10.3389/fphar.2021.709607

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。